Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors.

Okada, Yuka

Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors. [electronic resource] - Japanese journal of cancer research : Gann Apr 2002 - 436-44 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0910-5050

10.1111/j.1349-7006.2002.tb01275.x doi


Adenoviridae--genetics
Animals
Antibodies, Monoclonal--metabolism
Cell Line, Tumor
Cricetinae
Enterovirus--genetics
Flow Cytometry
Gene Transfer Techniques
Genetic Therapy--methods
Genetic Vectors
Green Fluorescent Proteins--metabolism
HeLa Cells
Humans
Integrin alphaV--metabolism
Lac Operon
Melanoma--metabolism
Melanoma, Experimental--therapy
Mice
Mice, Inbred C57BL
Mutation
Necrosis
Oligopeptides--chemistry
Polymerase Chain Reaction
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Tumor Necrosis Factor-alpha--genetics